Drug therapy for uveitis
The basis of every therapy decision is the distinction between an infectious and a non-infectious cause. If the uveitis is based on an infection or if there is a high degree of suspicion in this direction, the primary therapy consists of fighting the pathogen, e.g. anti-herpetic therapy for herpes or antibiotic therapy for a toxoplasmosis infection of the eye, accompanied by anti-inflammatory therapy to intercept the excessive inflammatory reaction. If the uveitis is primarily immunologically caused (within the scope of a systemic autoimmune disease or localized/isolated in the eye), anti-inflammatory treatment is the primary treatment. A large repertoire of medications is available. On the one hand, corticosteroids (cortisone), on the other hand immunomodulating drugs (conventional synthetic and biological disease-modifying anti-rheumatic drugs). Depending on the location of the inflammation, the severity of the inflammation and existing complications, we will work with you to develop an individual therapy strategy and adapt it accordingly as the disease progresses.